Oscotec Inc.

Translating science into medicine
Sign Up

Sign Up

Sign In
PRESS

NEWSROOM

Notice Press Releases Publications IR Materials
Home NEWSROOM Press Releases
TDefault
✔ Go Website with Viewer Search Write

  1. Yuhan ups investment in biotechs for immuno-oncology drug push

    Date2018-06-11 MediaTHE INVESTOR PipelineYuhan/Lazertinib
    Read More

  2. Yuhan to start phase-3 trial on lung cancer drug Lazertinib

    Date2019-12-12 MediaKBR (; Korea Biomedical Review) PipelineLazertinib
    Read More

  3. Profiles of Four New Stock-Billionaires

    Date2007-02-19 MediaMBN PipelineOscotec
    Read More

  4. Other news to note for March 2, 2021

    Date2021-03-02 MediaBioWorld PipelineOscotec
    Read More

  5. Oscotec`s SYK inhibitor Program Gets Korea Drug Fund Money

    Date2016-01-19 MediaScrip (Informa Pharma Intelligence) PipelineSYK-O-703
    Read More

  6. Oscotec`s acute leukemia treatment wins orphan drug status from FDA

    Date2018-11-23 MediaKBR (; Korea Biomedical Review) PipelineSKI-G-801
    Read More

  7. Oscotec wins exception policy for continued R&D for new drugs

    Date2019-06-25 MediaKBR (; Korea Biomedical Review) PipelineOscotec
    Read More

  8. Oscotec shares rebound on launch of US clinical trial

    Date2017-12-11 MediaKBR (; Korea Biomedical Review) PipelineSKI-G-801
    Read More

  9. Oscotec and Beactica Therapeutics announce license and collaboration agreement to develop new cancer drug

    Date2021-03-02 MediaCISION PipelineOscotec
    Read More

  10. More than half of Korean biopharma firms view R&D investments as assets.

    Date2018-03-14 MediaThe Korea Herald PipelineIndustry
    Read More

  11. Lazertinib Shows Promising Antitumor Activity in Patients With EGFR+ NSCLC

    Date2019-12-14 MediaTargeted Oncology PipelineLazertinib
    Read More

  12. Lazertinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: results from the dose escalation and dose expansion parts of a first-in-human, open-label, multicentre, phase 1-2 study

    Date2019-11-04 MediaTHE LANCET ONCOLOGY PipelineLazertinib
    Read More
Board Pagination Prev 1 2 Next
/ 2
© k2s0o1d6e0s8i2g7n. ALL RIGHTS RESERVED.
Requesting to the server, please wait.